Approach to cytomegalovirus infections in patients with ulcerative colitis

키워드

참고문헌 (56)

1. Cannon MJ, "Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection", Rev Med Virol, 20, pp.202~213 (2010)
2. Rowshani AT, "Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients", Transplantation, 79, pp.381~386 (2005)
3. Powell RD, "Cytomegalic inclusion disease and ulcerative colitis: report of a case in a young adult", Am J Med, 30, pp.334~340 (1961)
4. Kishore J, "Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome", J Med Microbiol, 53(Pt 11), pp.1155~1160 (2004)
5. Wada Y, "Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment", Dis Colon Rectum, 46(10 Suppl), pp.S59~S65 (2003)
6. Domenech E, "Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy", Inflamm Bowel Dis, 14, pp.1373~1379 (2008)
7. Maconi G, "Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection", Dig Liver Dis, 37, pp.418~423 (2005)
8. Cottone M, "Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn’s colitis", Am J Gastroenterol, 96, pp.773~775 (2001)
9. Kambham N, "Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study", Am J Surg Pathol, 28, pp.365~373 (2004)
10. Kim YS, "The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection: a prospective multicenter study", J Clin Gastroenterol, 46, pp.51~56 (2012)
11. Kim JJ, "Cytomegalovirus infection in patients with active inflammatory bowel disease", Dig Dis Sci, 55, pp.1059~1065 (2010)
12. Knosel T, "Prevalence of infectious pathogens in Crohn’s disease", Pathol Res Pract, 205, pp.223~230 (2009)
13. Nakase H, "Low prevalence of CMV infection in patients with Crohn’s disease in comparison with ulcerative colitis: effect of different immune response on prevalence of CMV infection", Dig Dis Sci, 55, pp.1498~1499 (2010)
14. Pillet S, "Management of cytomegalovirus infection in inflammatory bowel diseases", Dig Liver Dis, 44, pp.541~548 (2012)
15. Rahier JF, "Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease", J Crohns Colitis, 8, pp.443~468 (2014)
16. 문준일, "A case of hemophagocytic syndrome in a patient with fulminant ulcerative colitis superinfected by cytomegalovirus", The Korean Journal of Internal Medicine, 28(3), pp.352~355 (2013), 대한내과학회[DOI]
17. Matsumoto S, "What are the factors that affect hospitalization and surgery for aggravation of ulcerative colitis?", Eur J Gastroenterol Hepatol, 26, pp.282~287 (2014)
18. Park SH, "Severe disease activity and cytomegalovirus colitis are predictive of a nonresponse to infliximab in patients with ulcerative colitis", Dig Dis Sci, 58, pp.3592~3599 (2013)
19. 김유선, "Long-Term Outcomes of Cytomegalovirus Reactivation in Patients with Moderate to Severe Ulcerative Colitis: A Multicenter Study", Gut and Liver, 8(6), pp.643~647 (2014), 거트앤리버 발행위원회
20. Matsuoka K, "Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients", Am J Gastroenterol, 102, pp.331~337 (2007)
21. Yoshino T, "Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies", Inflamm Bowel Dis, 13, pp.1516~1521 (2007)
22. do Carmo AM, "Cytomegalovirus infection in inflammatory bowel disease is not associated with worsening of intestinal inflammatory activity", PLoS One, 9, pp.e111574~ (2014)
23. McCurdy JD, "A model for identifying cytomegalovirus in patients with inflammatory bowel disease", Clin Gastroenterol Hepatol, 13, pp.131~137 (2015)
24. Gauss A, "Intestinal cytomegalovirus infection in patients hospitalized for exacerbation of inflammatory bowel disease: a 10-year tertiary referral center experience", Eur J Gastroenterol Hepatol, 27, pp.712~720 (2015)
25. Sager K, "Review article: cytomegalovirus and inflammatory bowel disease", Aliment Pharmacol Ther, 41, pp.725~733 (2015)
26. Iida T, "Looking for endoscopic features of cytomegalovirus colitis: a study of 187 patients with active ulcerative colitis, positive and negative for cytomegalovirus", Inflamm Bowel Dis, 19, pp.1156~1163 (2013)
27. Suzuki H, "Specific endoscopic features of ulcerative colitis complicated by cytomegalovirus infection", World J Gastroenterol, 16, pp.1245~1251 (2010)
28. Kim JW, "Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis", J Crohns Colitis, 8, pp.693~701 (2014)
29. Jaeyoung Chun, "Usefulness of the Cytomegalovirus Antigenemia Assay in Patients With Ulcerative Colitis", Intestinal research, 13(1), pp.50~59 (2015), 대한장연구학회[DOI]
30. Sooyun Chang, "A Clinical Significance of Assessing Cytomegalovirus Infection Status in Patients With Ulcerative Colitis", Intestinal research, 13(1), pp.2~3 (2015), 대한장연구학회[DOI]
31. Kandiel A, "Cytomegalovirus colitis complicating inflammatory bowel disease", Am J Gastroenterol, 101, pp.2857~2865 (2006)
32. Beaugerie L, "Definition and diagnosis of cytomegalovirus colitis in patients infected by human immunodeficiency virus", J Acquir Immune Defic Syndr Hum Retrovirol, 14, pp.423~429 (1997)
33. McCoy MH, "qPCR increases sensitivity to detect cytomegalovirus in formalin-fixed, paraffin-embedded tissue of gastrointestinal biopsies", Hum Pathol, 45, pp.48~53 (2014)
34. Cotte L, "Diagnostic value of amplification of human cytomegalovirus DNA from gastrointestinal biopsies from human immunodeficiency virus-infected patients", J Clin Microbiol, 31, pp.2066~2069 (1993)
35. Roblin X, "Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis", Am J Gastroenterol, 106, pp.2001~2008 (2011)
36. Ciccocioppo R, "Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load mea surement", World J Gastroenterol, 21, pp.1915~1926 (2015)
37. Zidar N, "Diagnosing cytomegalovirus in patients with inflammatory bowel disease: by immunohistochemistry or polymerase chain reaction?", Virchows Arch, 466, pp.533~539 (2015)
38. McCurdy JD, "Detection of cytomegalovirus in patients with inflammatory bowel disease:where to biopsy and how many biopsies?", Inflamm Bowel Dis, 21, pp.2833~2838 (2015)
39. de la Hoz RE, "Diagnosis and treatment approaches of CMV infections in adult patients", J Clin Virol, 25(Suppl 2), pp.S1~S12 (2002)
40. Landry ML, "Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease", J Clin Microbiol, 31, pp.2851~2856 (1993)
41. Kornbluth A, "Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee", Am J Gastroenterol, 105, pp.501~523 (2010)
42. 최창환, "궤양성 대장염 치료 가이드라인 개정판", 대한소화기학회지, 69(1), pp.1~28 (2017), 대한소화기학회
43. Maconi G, "Long-term outcome of inflammatory bowel diseases with cytomegalovirus colitis: effect of antiviral treatment", Eur J Gastroenterol Hepatol, 26, pp.1146~1151 (2014)
44. Shukla T, "Antiviral therapy in steroid-refractory ulcerative colitis with cytomegalovirus: systematic review and meta-analysis", Inflamm Bowel Dis, 21, pp.2718~2725 (2015)
45. Jones A, "Effects of antiviral therapy for patients with inflammatory bowel disease and a positive intestinal biopsy for cytomegalovirus", Clin Gastroenterol Hepatol, 13, pp.949~955 (2015)
46. Omiya M, "The absence of large ulcer predicts latent cytomegalovirus infection in ulcerative colitis with positive mucosal viral assay", Intern Med, 49, pp.2277~2282 (2010)
47. Pillet S, "Cytomegalovirus and ulcerative colitis: place of antiviral therapy", World J Gastroenterol, 22, pp.2030~2045 (2016)
48. Criscuoli V, "Severe acute colitis associated with CMV: a prevalence study", Dig Liver Dis, 36, pp.818~820 (2004)
49. Papadakis KA, "Outcome of cytomegalovirus infections in patients with inflammatory bowel disease", Am J Gastroenterol, 96, pp.2137~2142 (2001)
50. Czock D, "Pharmacokinetics of valganciclovir and ganciclovir in renal impairment", Clin Pharmacol Ther, 72, pp.142~150 (2002)
51. Einsele H, "Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease", Lancet, 338, pp.1170~1172 (1991)
52. Ciccocioppo R., "Letter: cytomegalovirus infection in inflammatory bowel disease", Aliment Pharmacol Ther, 42, pp.127~129 (2015)
53. Landsman MJ, "Diagnosis and management of common gastrointestinal tract infectious diseases in ulcerative colitis and Crohn’s disease patients", Inflamm Bowel Dis, 20, pp.2503~2510 (2014)
54. D’Ovidio V, "Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy", J Clin Virol, 43, pp.180~183 (2008)
55. Lavagna A, "Infliximab and the risk of latent viruses reactivation in active Crohn’s disease", Inflamm Bowel Dis, 13, pp.896~902 (2007)
56. Pillet S, "Infliximab does not worsen outcomes during flare-ups associated with cytomegalovirus infection in patients with ulcerative colitis", Inflamm Bowel Dis, 21, pp.1580~1586 (2015)

관련 논문AI추천